MedTrace Logo

LOMA: Long-Term Management of Asthma

NCT00182481 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 112

Last updated 2005-12-16

No results posted yet for this study

Summary

The purpose of this study was to determine whether the use of induced sputum cell counts could guide treatment of asthma more effectively than the use of symptoms and breathing tests. The main outcomes where the time to the first exacerbation and the number of exacerbations.

Conditions

Interventions

PROCEDURE

Induced sputum cell counts

DRUG

inhaled corticosteroids and other asthma drugs

Sponsors & Collaborators

  • Canadian Institutes of Health Research (CIHR)

    collaborator OTHER_GOV

  • Hamilton Health Sciences Corporation

    lead OTHER

Principal Investigators

  • Frederick E Hargreave, MD · McMaster University

  • Louis-Philippe Boulet, MD · Laval University, Sainte-Foy, Quebec

  • Andre Cartier, MD · Hopital du Sacre Coeur, Montreal, PQ

  • Catherine Lemiere, MD · Hopital du Sacre Coeur, Montreal, PQ

  • Marcia Pizzichini, MD · Universidade Federal de Santa Catarina, Florianopolis, Brazil

  • Emilio Pizzichini, MD · Universidade Federal de Santa Catarina, Florianopolis, Brazil

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1999-09-30
Completion
2001-09-30

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00182481 on ClinicalTrials.gov